Flibanserin Hcl

We are engaged in manufacturing, exporting and supplying excellent quality Flibanserin HCl to our valuable clients.
MF: C20H22ClF3N4O
MW: 426.86
CASi 147359-76-0
Character: white powder
Purity(HPLC): 99.0%

Flibanserin (INN, USAN) (developmental code name BIMT-17; proposed trade names Girosa and Addyi) is a drug that is being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (HSDD). Development by Boehringer Ingelheim was halted in October 2010 following a negative evaluation by the U.S. Food and Drug Administration. The rights to the drug were then transferred to Sprout Pharmaceuticals, which is continuing the drug development process. On June 4, 2015, the panel to the FDA recommended approval of the drug by 18a 6. On August 18 2015, Flibanserin (Addyi) 100mg has been approved by the FDA.